St. John's Wort Depression In Term Paper

The study randomly assigned patients to an 8-week trial. One-third of patients received a uniform dose of St. John's Wort, another third a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for depression, and the final group received a placebo. The study participants who responded positively were followed for an additional 18 weeks. At the end of the first phase of the study, participants were measured on two scales, one for depression and one for overall functioning. There was no significant difference in rate of response for depression, but the scale for overall functioning was better for the antidepressant than for either St. John's Wort or placebo. ("Depression," 2000, National Institute of Health) Another study, described in the Journal of American Medicine also involved adult outpatients with major depression who were randomly assigned to receive St. John's Wort, an SSRI or a placebo. Of this study: "On the 2 primary outcome measures, neither sertraline [the antidepressant] nor H. perforatum [St. John's Wort] was significantly different from placebo." (JAMA, 2002, pp.1814) but another study in the British medical journal BMC found "significantly" more patients taking St. John's Wort, compared with either a placebo group or a group taking SSRIs, "showed treatment response and remission." (Kasper, et.al, 2006) There is a difficulty in quantifying 'depressed mood' in such studies, although all of the comparative studies use the same mood inventory to measure levels of depression in test subjects.

How the drugs mode of action resolves of affects the health problem at the cellular and organ system level?

The method of interaction of St. John's Wort upon the brain and physical body chemistry of the depressed patient is uncertain, as even the herb's efficacy is uncertain, although some speculate it may impact serotonin levels. The herb has been found to unpleasantly exacerbate the side effects of other SSRIs if taken in conjunction with other antidepressants. ("St. John's Wort," 2006, NCAM: National Council of Alternative Medicine)

Side effects that can occur

St. John's Wort appears to affect an important metabolic pathway that is used by many drugs prescribed to treat physical conditions such as AIDS, heart disease, depression, seizures, certain cancers, birth control...

...

("St. John's Wort," 2006, NCAM: National Council of Alternative Medicine)
Pregnancy classification

St. John's Wort has not been tested on pregnant women. It has been found that taking the herb can interfere with the ability of birth control pills to prevent pregnancy. ("St. John's Wort," 2006, NCAM: National Council of Alternative Medicine)

Toxicity

St. John's Wort may cause increased sensitivity to sunlight. Other side effects can include anxiety, dry mouth, dizziness, gastrointestinal symptoms, fatigue, headache, or sexual dysfunction. ("St. John's Wort," 2006, NCAM: National Council of Alternative Medicine)

Cost of a one months supply

St. John's Wort varies in cost, although its cost is seldom above $20 dollars for a month's supply, which is well below the cost of even generic SSRIs.

Most common dosage in generic and name brand if available

Most St. John's Wort capsules contain about 300mg of the herb, and suggest taking the capsules three times a day, or a daily dose of 900mg.

Works Cited

Depression." (2006) Healthy Place. Retrieved 23 Oct 2006 at http://www.healthyplace.com/Communities/depression/causes.asp

Depression." (2000) National Institute of Health. Retrieved 23 Oct 2006 at http://www.nimh.nih.gov/publicat/depression.cfm

Hypericum Depression Trial Study Group."(2002). Journal of the American Medical

Association. 287(14): 1807-1814. Retrieved 23 Oct 2006 at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11939866&query_hl=2

Kasper, S., I.G. Anghelescu, a. Szegedi, a. Dienel & M. Kieser. "Superior efficacy of St.

John's Wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial." (2006) BMC Med 2006 Jun 23:4:14. Retrieved 23 Oct 2006 at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&db=pubmed&cmd=Retrieve&dopt=abstractplus&list_uids=16796730

St. John's Wort." (2006). NCAM: National Council of Alternative Medicine. Retrieved 23 Oct 2006 at http://nccam.nih.gov/health/stjohnswort/

Sources Used in Documents:

Works Cited

Depression." (2006) Healthy Place. Retrieved 23 Oct 2006 at http://www.healthyplace.com/Communities/depression/causes.asp

Depression." (2000) National Institute of Health. Retrieved 23 Oct 2006 at http://www.nimh.nih.gov/publicat/depression.cfm

Hypericum Depression Trial Study Group."(2002). Journal of the American Medical

Association. 287(14): 1807-1814. Retrieved 23 Oct 2006 at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11939866&query_hl=2
John's Wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial." (2006) BMC Med 2006 Jun 23:4:14. Retrieved 23 Oct 2006 at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&db=pubmed&cmd=Retrieve&dopt=abstractplus&list_uids=16796730
St. John's Wort." (2006). NCAM: National Council of Alternative Medicine. Retrieved 23 Oct 2006 at http://nccam.nih.gov/health/stjohnswort/


Cite this Document:

"St John's Wort Depression In" (2006, October 24) Retrieved April 19, 2024, from
https://www.paperdue.com/essay/st-john-wort-depression-in-72593

"St John's Wort Depression In" 24 October 2006. Web.19 April. 2024. <
https://www.paperdue.com/essay/st-john-wort-depression-in-72593>

"St John's Wort Depression In", 24 October 2006, Accessed.19 April. 2024,
https://www.paperdue.com/essay/st-john-wort-depression-in-72593

Related Documents

ETHNOBOTANY (Biology Class). John's Wort John's Wort (Hypericum perforatum) is increasingly used as a natural way of treating mild to moderate depression. "Hypericum has a thymoleptic action which results in an improved sense of well-being. It has long been used as a nerve healer in melancholic conditions, depression, exhaustion and convalescence. It is also used to treat conditions where there is a degree of overtension, such as insomnia, cramps and colic

Another clinical study was done on the effectiveness of Kava extract for treating anxiety. This study analysis was aimed at assessing the evidence for or against the effectiveness of Kava extract as a symptomatic treatment for anxiety. Double-blind, randomized, placebo-controlled trials of oral Kava extract for the treatment of anxiety were analyzed. Superiority of Kava extract over placebo was suggested by all seven reviewed trials. The meta-analysis of three trials

Pharmacology: Moclobemide Moclobemide is classified as an antidepressant, a MAO (monoamine oxidase) inhibitor. Antidepressants are designed to inhibit the reuptake or reabsorbtion of specific neurotransmitters, increasing the levels of these neurotransmitters around the nerves of the brain (Gbemudu, 2011:1). Neurotransmitters such as serotonin, dopamine and norepinephrine (noradrenaline) are often called 'feel good' chemicals that elevate the patient's mood. Drug class A deficit of mood-enhancing chemicals is associated with depression, although there is no

Diabetic Patient
PAGES 7 WORDS 2064

Question a. Is his current therapy working? (350 words) (20 marks) Justify your answer by using the evidence presented in the case study. In your answer, you should also explain the pathophysiology of any of the signs/symptoms observed.Present universal guidelines for diabetes mellitus type 2 (T2D) management encourage preliminary changes in lifestyle (i.e., exercise and diet). Metformin is favored and prescribed as a first-line anti-diabetes treatment for diagnosed individuals who

These skills are vital for them to make an impact, considering the powerful relationship between leadership strength and influence. (...) In Australia the following study has noted a change in skill mix may be necessary: Rising demand for health services, cost containment and shortages of nurses, midwives and other health workers were cited as the major catalyst for skill mix changes by ICN (2005d in ICN 2006). ICN (2004 in ICN

History of the Problem Rachel Evans (2011) lists a number of nutritional therapies for the treatment of depression, ranging from St. John's Wort to "dan zhi xiao yao, a traditional Chinese medicine." Alternative medicine has often been seen as a supplement to the treatment of depression in the past. Other treatments have included the famous lobotomy technique designed by Portuguese neurologist Antonio Egas Moniz, who was awarded the Nobel Prize for